Sjögren's syndrome and the epithelial target: A comprehensive review

Journal of Autoimmunity

Volumn 42, Issue , 2013, Pages 7-18

  Barrera, M J ^a   Bahamondes, V ^a   Sepulveda D ^a   Quest, A F G ^a   Castro, I ^a   Cortes J ^a   Aguilera, S ^b   Urzua U ^a   Molina, C ^c   Perez P ^a   Ewert, P ^a   Alliende, C ^a   Hermoso, M A ^a   Gonzalez S ^c,d   Leyton, C ^a   Gonzalez M J ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital Exequiel González Cortés   (Chile)

^c UNIVERSIDAD MAYOR   (Chile)

^d UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

Acinar cell architecture; Cell polarity; Ectopic exocytosis; Epitheliitis; Salivary glands; Secretory molecular machinery; Sj gren's syndrome

Indexed keywords

GUANOSINE TRIPHOSPHATASE; RAB PROTEIN; SNARE PROTEIN; TIGHT JUNCTION PROTEIN;

ACINAR CELL; CELL FUNCTION; CELL INTERACTION; CELL POLARITY; CHEMICAL ANALYSIS; CYTOLOGY; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GRANULE CELL; HUMAN; IMMUNOBIOLOGY; MECHANICS; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; SJOEGREN SYNDROME; TIGHT JUNCTION;

ACINAR CELLS; ANIMALS; CELL ADHESION; CELL POLARITY; CYTOKINES; EPITHELIAL CELLS; EXOCYTOSIS; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; MUCINS; SJOGREN'S SYNDROME; SNARE PROTEINS; TIGHT JUNCTIONS;

EID: 84877127160     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2013.02.001     Document Type: Review

References (146)

1. Barrera M.J., Sanchez M., Aguilera S., Alliende C., Bahamondes V., Molina C., et al. Aberrant localization of fusion receptors involved in regulated exocytosis in salivary glands of Sjogren's syndrome patients is linked to ectopic mucin secretion. J Autoimmun 2012, 39:83-92.
2. Park K., Haberberger R.V., Gordon T.P., Jackson M.W. Antibodies interfering with the type 3 muscarinic receptor pathway inhibit gastrointestinal motility and cholinergic neurotransmission in Sjogren's syndrome. Arthritis Rheum 2011, 63:1426-1434.
3. Inoue H., Mishima K., Yamamoto-Yoshida S., Ushikoshi-Nakayama R., Nakagawa Y., Yamamoto K., et al. Aryl hydrocarbon receptor-mediated induction of EBV reactivation as a risk factor for Sjogren's syndrome. J Immunol 2012, 188:4654-4662.
4. Cornec D., Devauchelle-Pensec V., Tobon G.J., Pers J.O., Jousse-Joulin S., Saraux A. B cells in Sjogren's syndrome: from pathophysiology to diagnosis and treatment. J Autoimmun 2012, 39:161-167.
5. Greenwell-Wild T., Moutsopoulos N.M., Gliozzi M., Kapsogeorgou E., Rangel Z., Munson P.J., et al. Chitinases in the salivary glands and circulation of patients with Sjogren's syndrome: macrophage harbingers of disease severity. Arthritis Rheum 2011, 63:3103-3115.
6. Baldini C., Talarico R., Tzioufas A.G., Bombardieri S. Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun 2012, 39:9-14.
7. Cornec D., Jousse-Joulin S., Pers J.O., Marhadour T., Cochener B., Boisrame-Gastrin S., et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjogren's syndrome: toward new diagnostic criteria?. Arthritis Rheum 2013, 65:216-225.
8. Nguyen C.Q., Kim H., Cornelius J.G., Peck A.B. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3. J Immunol 2007, 179:2318-2329.
9. Guellec D., Cornec D., Jousse-Joulin S., Marhadour T., Marcorelles P., Pers J.O., et al. Diagnostic value of labial minor salivary gland biopsy for Sjogren's syndrome: a systematic review. Autoimmun Rev 2013 Jan, 12(3):416-420.
10. Le Pottier L., Devauchelle V., Fautrel A., Daridon C., Saraux A., Youinou P., et al. Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol 2009, 182:3540-3547.
11. Mavragani C.P., Fragoulis G.E., Moutsopoulos H.M. Endocrine alterations in primary Sjogren's syndrome: an overview. J Autoimmun 2012, 39:354-358.
12. Saadoun D., Terrier B., Bannock J., Vazquez T., Massad C., Kang I., et al. Expansion of autoreactive unresponsive CD21(-/low) B cells in Sjogren's syndrome associated lymphoproliferation. Arthritis Rheum 2012 Dec 26, http://dx.doi.org/10.1002/art.37828 [Epub ahead of print].
13. Ice J.A., Li H., Adrianto I., Lin P.C., Kelly J.A., Montgomery C.G., et al. Genetics of Sjogren's syndrome in the genome-wide association era. J Autoimmun 2012, 39:57-63.
14. Cruz-Tapias P., Rojas-Villarraga A., Maier-Moore S., Anaya J.M. HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev 2012, 11:281-287.
15. Sakai A., Sugawara Y., Kuroishi T., Sasano T., Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008, 181:2898-2906.
16. Abdulahad W.H., Kroese F.G., Vissink A., Bootsma H. Immune regulation and B-cell depletion therapy in patients with primary Sjogren's syndrome. J Autoimmun 2012, 39:103-111.
17. Takahashi H., Yamamoto M., Tabeya T., Suzuki C., Naishiro Y., Shinomura Y., et al. The immunobiology and clinical characteristics of IgG4 related diseases. J Autoimmun 2012, 39:93-96.
18. Varin M.M., Guerrier T., Devauchelle-Pensec V., Jamin C., Youinou P., Pers J.O. Sjogren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation. Autoimmun Rev 2012, 11:252-258.
19. Bombardieri M., Barone F., Lucchesi D., Nayar S., van den Berg W.B., Proctor G., et al. Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol 2012, 189:3767-3776.
20. Lindop R., Arentz G., Chataway T.K., Thurgood L.A., Jackson M.W., Reed J.H., et al. Molecular signature of a public clonotypic autoantibody in primary Sjogren's syndrome: a " forbidden" clone in systemic autoimmunity. Arthritis Rheum 2011, 63:3477-3486.
21. Brito-Zeron P., Retamozo S., Gandia M., Akasbi M., Perez-De-Lis M., Diaz-Lagares C., et al. Monoclonal gammopathy related to Sjogren syndrome: a key marker of disease prognosis and outcomes. J Autoimmun 2012, 39:43-48.
22. Castro I., Sepulveda D., Cortes J., Quest A.F., Barrera M.J., Bahamondes V., et al. Oral dryness in Sjogren's syndrome patients. Not just a question of water. Autoimmun Rev 2012 Nov 30, http://dx.doi.org/10.1016/j.autrev.2012.10.018 [Epub ahead of print].
23. Seror R., Bootsma H., Bowman S.J., Dorner T., Gottenberg J.E., Mariette X., et al. Outcome measures for primary Sjogren's syndrome. J Autoimmun 2012, 39:97-102.
24. Tzioufas A.G., Kapsogeorgou E.K., Moutsopoulos H.M. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. J Autoimmun 2012, 39:4-8.
25. Pavlakis P.P., Alexopoulos H., Kosmidis M.L., Mamali I., Moutsopoulos H.M., Tzioufas A.G., et al. Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun 2012, 39:27-33.
26. Ota M., Duong B.H., Torkamani A., Doyle C.M., Gavin A.L., Ota T., et al. Regulation of the B cell receptor repertoire and self-reactivity by BAFF. J Immunol 2010, 185:4128-4136.
27. Solans-Laque R., Lopez-Hernandez A., Bosch-Gil J.A., Palacios A., Campillo M., Vilardell-Tarres M. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjogren's syndrome. Semin Arthritis Rheum 2011, 41:415-423.
28. Shen L., Suresh L., Wu J., Xuan J., Li H., Zhang C., et al. A role for lymphotoxin in primary Sjogren's disease. J Immunol 2010, 185:6355-6363.
29. Risselada A.P., Looije M.F., Kruize A.A., Bijlsma J.W., van Roon J.A. The role of ectopic germinal centers in the immunopathology of primary Sjogren's syndrome: a systematic review. Semin Arthritis Rheum 2013 Feb, 42(4):368-376.
30. Guerrier T., Le Pottier L., Devauchelle V., Pers J.O., Jamin C., Youinou P. Role of Toll-like receptors in primary Sjogren's syndrome with a special emphasis on B-cell maturation within exocrine tissues. J Autoimmun 2012, 39:69-76.
31. Manoussakis M.N., Tsinti M., Kapsogeorgou E.K., Moutsopoulos H.M. The salivary gland epithelial cells of patients with primary Sjogren's syndrome manifest significantly reduced responsiveness to 17beta-estradiol. J Autoimmun 2012, 39:64-68.
32. Pauley K.M., Gauna A.E., Grichtchenko, Chan E.K., Cha S. A secretagogue-small interfering RNA conjugate confers resistance to cytotoxicity in a cell model of Sjogren's syndrome. Arthritis Rheum 2011, 63:3116-3125.
33. Konttinen Y.T., Fuellen G., Bing Y., Porola P., Stegaev V., Trokovic N., et al. Sex steroids in Sjogren's syndrome. J Autoimmun 2012, 39:49-56.
34. Amador-Patarroyo M.J., Arbelaez J.G., Mantilla R.D., Rodriguez-Rodriguez A., Cardenas-Roldan J., Pineda-Tamayo R., et al. Sjogren's syndrome at the crossroad of polyautoimmunity. J Autoimmun 2012, 39:199-205.
35. Tzioufas A.G., Vlachoyiannopoulos P.G. Sjogren's syndrome: an update on clinical, basic and diagnostic therapeutic aspects. J Autoimmun 2012, 39:1-3.
36. Bournia V.K., Vlachoyiannopoulos P.G. Subgroups of Sjogren syndrome patients according to serological profiles. J Autoimmun 2012, 39:15-26.
37. Singh N., Cohen P.L. The T cell in Sjogren's syndrome: force majeure, not spectateur. J Autoimmun 2012, 39:229-233.
38. Tanaka A., Moriyama M., Nakashima H., Miyake K., Hayashida J.N., Maehara T., et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum 2012, 64:254-263.
39. Yao Y., Liu Z., Jallal B., Shen N., Ronnblom L. Type I interferons in Sjogren's syndrome. Autoimmun Rev 2012 Nov 30, http://dx.doi.org/10.1016/j.autrev.2012.10.006 [Epub ahead of print].
40. Sharma R., Deshmukh U.S., Zheng L., Fu S.M., Ju S.T. X-linked Foxp3 (Scurfy) mutation dominantly inhibits submandibular gland development and inflammation respectively through adaptive and innate immune mechanisms. J Immunol 2009, 183:3212-3218.
41. Fox R.I. The salivary gland epithelial cell in Sjogren's syndrome: what are the steps involved in wounding or killing their secretory function?. J Rheumatol 2012, 39:1117-1119.
42. Manoussakis M.N., Kapsogeorgou E.K. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun 2010, 35:219-224.
43. Peck A.B., Saylor B.T., Nguyen L., Sharma A., She J.X., Nguyen C.Q., et al. Gene expression profiling of early-phase Sjogren's syndrome in C57BL/6.NOD-Aec1Aec2 mice identifies focal adhesion maturation associated with infiltrating leukocytes. Invest Ophthalmol Vis Sci 2011, 52:5647-5655.
44. Perez P., Aguilera S., Olea N., Alliende C., Molina C., Brito M., et al. Aberrant localization of ezrin correlates with salivary acini disorganization in Sjogren's syndrome. Rheumatology (Oxford) 2010, 49:915-923.
45. Ewert P., Aguilera S., Alliende C., Kwon Y.J., Albornoz A., Molina C., et al. Disruption of tight junction structure in salivary glands from Sjogren's syndrome patients is linked to proinflammatory cytokine exposure. Arthritis Rheum 2010, 62:1280-1289.
46. Moutsopoulos H.M. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994, 72:162-165.
47. Mitsias D.I., Kapsogeorgou E.K., Moutsopoulos H.M. Sjogren's syndrome: why autoimmune epithelitis?. Oral Dis 2006, 12:523-532.
48. Castle D., Castle A. Intracellular transport and secretion of salivary proteins. Crit Rev Oral Biol Med 1998, 9:4-22.
49. Aps J.K., Martens L.C. Review: the physiology of saliva and transfer of drugs into saliva. Forensic Sci Int 2005, 150:119-131.
50. Weisz O.A., Rodriguez-Boulan E. Apical trafficking in epithelial cells: signals, clusters and motors. J Cell Sci 2009, 122:4253-4266.
51. Castle A.M., Huang A.Y., Castle J.D. The minor regulated pathway, a rapid component of salivary secretion, may provide docking/fusion sites for granule exocytosis at the apical surface of acinar cells. J Cell Sci 2002, 115:2963-2973.
52. Baum B.J., Dai Y., Hiramatsu Y., Horn V.J., Ambudkar I.S. Signaling mechanisms that regulate saliva formation. Crit Rev Oral Biol Med 1993, 4:379-384.
53. Gorr S.U., Venkatesh S.G., Darling D.S. Parotid secretory granules: crossroads of secretory pathways and protein storage. J Dent Res 2005, 84:500-509.
54. 3 secretion. Physiol Rev 2012, 92:39-74.
55. Kawedia J.D., Nieman M.L., Boivin G.P., Melvin J.E., Kikuchi K., Hand A.R., et al. Interaction between transcellular and paracellular water transport pathways through Aquaporin 5 and the tight junction complex. Proc Natl Acad Sci U S A 2007, 104:3621-3626.
56. Bryant D.M., Mostov K.E. From cells to organs: building polarized tissue. Nat Rev Mol Cell Biol 2008, 9:887-901.
57. Rodriguez-Boulan E., Kreitzer G., Musch A. Organization of vesicular trafficking in epithelia. Nat Rev Mol Cell Biol 2005, 6:233-247.
58. Okamoto C.T., Forte J.G. Vesicular trafficking machinery, the actin cytoskeleton, and H+-K+-ATPase recycling in the gastric parietal cell. J Physiol 2001, 532:287-296.
59. Li R., Gundersen G.G. Beyond polymer polarity: how the cytoskeleton builds a polarized cell. Nat Rev Mol Cell Biol 2008, 9:860-873.
60. Arpin M., Chirivino D., Naba A., Zwaenepoel I. Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr 2011, 5:199-206.
61. Barret C., Roy C., Montcourrier P., Mangeat P., Niggli V. Mutagenesis of the phosphatidylinositol 4,5-bisphosphate (PIP(2)) binding site in the NH(2)-terminal domain of ezrin correlates with its altered cellular distribution. J Cell Biol 2000, 151:1067-1080.
62. McRobert E.A., Young A.N., Bach L.A. Advanced glycation end-products induce calpain-mediated degradation of ezrin. FEBS J 2012, 279:3240-3250.
63. Casaletto J.B., Saotome I., Curto M., McClatchey A.I. Ezrin-mediated apical integrity is required for intestinal homeostasis. Proc Natl Acad Sci U S A 2011, 108:11924-11929.
64. Takeuchi K., Sato N., Kasahara H., Funayama N., Nagafuchi A., Yonemura S., et al. Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 1994, 125:1371-1384.
65. Saotome I., Curto M., McClatchey A.I. Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 2004, 6:855-864.
66. Miyoshi J., Takai Y. Structural and functional associations of apical junctions with cytoskeleton. Biochim Biophys Acta 2008, 1778:670-691.
67. Mitic L.L., Van Itallie C.M., Anderson J.M. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000, 279:G250-G254.
68. Furuse M. Molecular basis of the core structure of tight junctions. Cold Spring Harb Perspect Biol 2010, 2:a002907.
69. Ruffer C., Gerke V. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol 2004, 83:135-144.
70. Gonzalez-Mariscal L., Betanzos A., Nava P., Jaramillo B.E. Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44.
71. Itoh M., Furuse M., Morita K., Kubota K., Saitou M., Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999, 147:1351-1363.
72. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000, 11:4131-4142.
73. Fanning A.S., Anderson J.M. PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 1999, 103:767-772.
74. Arcangeli M.L., Frontera V., Aurrand-Lions M. Function of junctional adhesion molecules (JAMs) in leukocyte migration and homeostasis. Arch Immunol Ther Exp (Warsz) 2013 Feb, 61(1):15-23.
75. Ito M., Kodama M., Masuko M., Yamaura M., Fuse K., Uesugi Y., et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 2000, 86:275-280.
76. Zen K., Liu Y., McCall I.C., Wu T., Lee W., Babbin B.A., et al. Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils. Mol Biol Cell 2005, 16:2694-2703.
77. Itoh M., Nagafuchi A., Moroi S., Tsukita S. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 1997, 138:181-192.
78. Fanning A.S., Jameson B.J., Jesaitis L.A., Anderson J.M. The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 1998, 273:29745-29753.
79. Muthuswamy S.K., Xue B. Cell polarity as a regulator of cancer cell behavior plasticity. Annu Rev Cell Dev Biol 2012, 28:599-625.
80. Suzuki A., Akimoto K., Ohno S. Protein kinase C lambda/iota (PKClambda/iota): a PKC isotype essential for the development of multicellular organisms. J Biochem 2003, 133:9-16.
81. Pieczynski J., Margolis B. Protein complexes that control renal epithelial polarity. Am J Physiol Ren Physiol 2011, 300:F589-F601.
82. Tanos B., Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008, 27:6939-6957.
83. Comer F.I., Parent C.A. Phosphoinositides specify polarity during epithelial organ development. Cell 2007, 128:239-240.
84. Martin-Belmonte F., Gassama A., Datta A., Yu W., Rescher U., Gerke V., et al. PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 2007, 128:383-397.
85. Weiner O.D., Neilsen P.O., Prestwich G.D., Kirschner M.W., Cantley L.C., Bourne H.R. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat Cell Biol 2002, 4:509-513.
86. Gassama-Diagne A., Yu W., ter Beest M., Martin-Belmonte F., Kierbel A., Engel J., et al. Phosphatidylinositol-3,4,5-trisphosphate regulates the formation of the basolateral plasma membrane in epithelial cells. Nat Cell Biol 2006, 8:963-970.
87. Bleich M., Shan Q., Himmerkus N. Calcium regulation of tight junction permeability. Ann N Y Acad Sci 2012, 1258:93-99.
88. Chalmers A.D., Whitley P. Continuous endocytic recycling of tight junction proteins: how and why?. Essays Biochem 2012, 53:41-54.
89. Balda M.S., Gonzalez-Mariscal L., Contreras R.G., Macias-Silva M., Torres-Marquez M.E., Garcia-Sainz J.A., et al. Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J Membr Biol 1991, 122:193-202.
90. Mellor H., Parker P.J. The extended protein kinase C superfamily. Biochem J 1998, 332(Pt 2):281-292.
91. Joberty G., Petersen C., Gao L., Macara I.G. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2000, 2:531-539.
92. Lin D., Edwards A.S., Fawcett J.P., Mbamalu G., Scott J.D., Pawson T. A mammalian PAR-3-PAR-6 complex implicated in Cdc42/Rac1 and aPKC signalling and cell polarity. Nat Cell Biol 2000, 2:540-547.
93. Nunbhakdi-Craig V., Machleidt T., Ogris E., Bellotto D., White C.L., Sontag E. Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 2002, 158:967-978.
94. Matter K., Balda M.S. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-236.
95. Terry S., Nie M., Matter K., Balda M.S. Rho signaling and tight junction functions. Physiology (Bethesda) 2010, 25:16-26.
96. Utech M., Ivanov A.I., Samarin S.N., Bruewer M., Turner J.R., Mrsny R.J., et al. Mechanism of IFN-gamma-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005, 16:5040-5052.
97. Gopalakrishnan S., Raman N., Atkinson S.J., Marrs J.A. Rho GTPase signaling regulates tight junction assembly and protects tight junctions during ATP depletion. Am J Physiol 1998, 275:C798-C809.
98. Takaishi K., Sasaki T., Kotani H., Nishioka H., Takai Y. Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol 1997, 139:1047-1059.
99. Gonzalez-Mariscal L., Tapia R., Chamorro D. Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 2008, 1778:729-756.
100. Goicovich E., Molina C., Perez P., Aguilera S., Fernandez J., Olea N., et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjogren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum 2003, 48:2573-2584.
101. Konttinen Y.T., Halinen S., Hanemaaijer R., Sorsa T., Hietanen J., Ceponis A., et al. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol 1998, 17:335-347.
102. Perez P., Goicovich E., Alliende C., Aguilera S., Leyton C., Molina C., et al. Differential expression of matrix metalloproteinases in labial salivary glands of patients with primary Sjogren's syndrome. Arthritis Rheum 2000, 43:2807-2817.
103. Perez P., Kwon Y.J., Alliende C., Leyton L., Aguilera S., Molina C., et al. Increased acinar damage of salivary glands of patients with Sjogren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 2005, 52:2751-2760.
104. Kwon Y.J., Perez P., Aguilera S., Molina C., Leyton L., Alliende C., et al. Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjogren's syndrome. Arthritis Rheum 2006, 54:3465-3475.
105. Gonzalez S., Aguilera S., Alliende C., Urzua U., Quest A.F., Herrera L., et al. Alterations in type I hemidesmosome components suggestive of epigenetic control in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2011, 63:1106-1115.
106. Velozo J., Aguilera S., Alliende C., Ewert P., Molina C., Perez P., et al. Severe alterations in expression and localisation of {alpha}6{beta}4 integrin in salivary gland acini from patients with Sjogren syndrome. Ann Rheum Dis 2009, 68:991-996.
107. Gonzalez S., Aguilera S., Urzua U., Quest A.F., Molina C., Alliende C., et al. Mechanotransduction and epigenetic control in autoimmune diseases. Autoimmun Rev 2010, 10:175-179.
108. Perez P., Anaya J.M., Aguilera S., Urzua U., Munroe D., Molina C., et al. Gene expression and chromosomal location for susceptibility to Sjogren's syndrome. J Autoimmun 2009, 33:99-108.
109. Kapsogeorgou E.K., Abu-Helu R.F., Moutsopoulos H.M., Manoussakis M.N. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum 2005, 52:1517-1521.
110. Fevrier B., Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004, 16:415-421.
111. Gallo A., Tandon M., Alevizos I., Illei G.G. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One 2012, 7:e30679.
112. Goldblum S.E., Ding X., Campbell-Washington J. TNF-alpha induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 1993, 264:C894-C905.
113. Petrache I., Birukova A., Ramirez S.I., Garcia J.G., Verin A.D. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Cell Mol Biol 2003, 28:574-581.
114. Gertzberg N., Neumann P., Rizzo V., Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2004, 286:L37-L48.
115. McKenzie J.A., Ridley A.J. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J Cell Physiol 2007, 213:221-228.
116. Petrache I., Crow M.T., Neuss M., Garcia J.G. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. Biochem Biophys Res Commun 2003, 306:244-249.
117. Shivanna M., Rajashekhar G., Srinivas S.P. Barrier dysfunction of the corneal endothelium in response to TNF-alpha: role of p38 MAP kinase. Invest Ophthalmol Vis Sci 2009, 51:1575-1582.
118. Petrache I., Verin A.D., Crow M.T., Birukova A., Liu F., Garcia J.G. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1168-L1178.
119. Wang Q., Yerukhimovich M., Gaarde W.A., Popoff I.J., Doerschuk C.M. MKK3 and -6-dependent activation of p38alpha MAP kinase is required for cytoskeletal changes in pulmonary microvascular endothelial cells induced by ICAM-1 ligation. Am J Physiol Lung Cell Mol Physiol 2005, 288:L359-L369.
120. Shen L. Tight junctions on the move: molecular mechanisms for epithelial barrier regulation. Ann N Y Acad Sci 2012, 1258:9-18.
121. Lang T., Jahn R. Core proteins of the secretory machinery. Handb Exp Pharmacol 2008, 107-127.
122. Jahn R., Fasshauer D. Molecular machines governing exocytosis of synaptic vesicles. Nature 2012, 490:201-207.
123. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol Rev 2001, 81:153-208.
124. Pereira-Leal J.B., Seabra M.C. Evolution of the Rab family of small GTP-binding proteins. J Mol Biol 2001, 313:889-901.
125. Cherfils J., Zeghouf M. Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 2013, 93:269-309.
126. Hutagalung A.H., Novick P.J. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 2011, 91:119-149.
127. Novick P., Zerial M. The diversity of Rab proteins in vesicle transport. Curr Opin Cell Biol 1997, 9:496-504.
128. Ohnishi H., Ernst S.A., Wys N., McNiven M., Williams J.A. Rab3D localizes to zymogen granules in rat pancreatic acini and other exocrine glands. Am J Physiol 1996, 271:G531-G538.
129. Raffaniello R.D., Lin J., Schwimmer R., Ojakian G.K. Expression and localization of Rab3D in rat parotid gland. Biochim Biophys Acta 1999, 1450:352-363.
130. Schluter O.M., Khvotchev M., Jahn R., Sudhof T.C. Localization versus function of Rab3 proteins. Evidence for a common regulatory role in controlling fusion. J Biol Chem 2002, 277:40919-40929.
131. da Costa S.R., Wu K., Veigh M.M., Pidgeon M., Ding C., Schechter J.E., et al. Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development. Exp Eye Res 2006, 82:33-45.
132. Bahamondes V., Albornoz A., Aguilera S., Alliende C., Molina C., Castro I., et al. Changes in Rab3D expression and distribution in the acini of Sjogren's syndrome patients are associated with loss of cell polarity and secretory dysfunction. Arthritis Rheum 2011, 63:3126-3135.
133. Mitra S., Cheng K.W., Mills G.B. Rab GTPases implicated in inherited and acquired disorders. Semin Cell Dev Biol 2010, 22:57-68.
134. Lee B.H., Gauna A.E., Pauley K.M., Park Y.J., Cha S. Animal models in autoimmune diseases: lessons learned from mouse models for Sjogren's syndrome. Clin Rev Allergy Immunol 2012, 42:35-44.
135. Jena B.P. Role of SNAREs in membrane fusion. Adv Exp Med Biol 2011, 713:13-32.
136. Jahn R., Scheller R.H. SNAREs-engines for membrane fusion. Nat Rev Mol Cell Biol 2006, 7:631-643.
137. Sudhof T.C., Rizo J. Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol 2011, 3.
138. Sudhof T.C., Rothman J.E. Membrane fusion: grappling with SNARE and SM proteins. Science 2009, 323:474-477.
139. Ramakrishnan N.A., Drescher M.J., Drescher D.G. The SNARE complex in neuronal and sensory cells. Mol Cell Neurosci 2012, 50:58-69.
140. Weng N., Thomas D.D., Groblewski G.E. Pancreatic acinar cells express vesicle-associated membrane protein 2- and 8-specific populations of zymogen granules with distinct and overlapping roles in secretion. J Biol Chem 2007, 282:9635-9645.
141. Wang C.C., Shi H., Guo K., Ng C.P., Li J., Gan B.Q., et al. VAMP8/endobrevin as a general vesicular SNARE for regulated exocytosis of the exocrine system. Mol Biol Cell 2007, 18:1056-1063.
142. Wang C.C., Ng C.P., Shi H., Liew H.C., Guo K., Zeng Q., et al. A role for VAMP8/endobrevin in surface deployment of the water channel aquaporin 2. Mol Cell Biol 2010, 30:333-343.
143. Zhu D., Zhang Y., Lam P.P., Dolai S., Liu Y., Cai E.P., et al. Dual role of VAMP8 in regulating insulin exocytosis and islet beta cell growth. Cell Metab 2012, 16:238-249.
144. Stoeckelhuber M., Scherer E.Q., Janssen K.P., Slotta-Huspenina J., Loeffelbein D.J., Rohleder N.H., et al. The human submandibular gland: immunohistochemical analysis of SNAREs and cytoskeletal proteins. J Histochem Cytochem 2012, 60:110-120.
145. Cosen-Binker L.I., Binker M.G., Wang C.C., Hong W., Gaisano H.Y. VAMP8 is the v-SNARE that mediates basolateral exocytosis in a mouse model of alcoholic pancreatitis. J Clin Invest 2008, 118:2535-2551.
146. Thorn P., Gaisano H. Molecular control of compound exocytosis: a key role for VAMP8. Commun Integr Biol 2012, 5:61-63.